vs
Side-by-side financial comparison of CG Oncology, Inc. (CGON) and Virgin Galactic Holdings, Inc (SPCE). Click either name above to swap in a different company.
Virgin Galactic Holdings, Inc is the larger business by last-quarter revenue ($4.2M vs $2.3M, roughly 1.8× CG Oncology, Inc.). CG Oncology, Inc. runs the higher net margin — -1779.0% vs -2222.2%, a 443.1% gap on every dollar of revenue. On growth, CG Oncology, Inc. posted the faster year-over-year revenue change (409.2% vs 125.5%). CG Oncology, Inc. produced more free cash flow last quarter ($-36.2M vs $-113.5M).
CG Oncology, Inc. is a clinical-stage biotechnology company focused on developing innovative targeted immunotherapies for urological cancers including non-muscle invasive bladder cancer. It primarily operates in the U.S. market, advancing pipeline candidates to address unmet medical needs for patients with limited treatment options.
Virgin Galactic Holdings, Inc. is a British-American spaceflight company founded by Richard Branson and the Virgin Group conglomerate, which retains an 11.9% stake through Virgin Investments Limited.
CGON vs SPCE — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2024
| Metric | | |
|---|---|---|
| Revenue | $2.3M | $4.2M |
| Net Profit | $-41.3M | $-93.8M |
| Gross Margin | — | -546.6% |
| Operating Margin | -2097.3% | -2412.1% |
| Net Margin | -1779.0% | -2222.2% |
| Revenue YoY | 409.2% | 125.5% |
| Net Profit YoY | -29.9% | 30.2% |
| EPS (diluted) | $-0.52 | $-4.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.3M | — | ||
| Q3 25 | $1.7M | — | ||
| Q2 25 | $0 | — | ||
| Q4 24 | $456.0K | — | ||
| Q2 24 | — | $4.2M | ||
| Q1 24 | $529.0K | $2.0M | ||
| Q4 23 | — | $2.8M | ||
| Q3 23 | — | $1.7M |
| Q4 25 | $-41.3M | — | ||
| Q3 25 | $-43.8M | — | ||
| Q2 25 | $-41.4M | — | ||
| Q4 24 | $-31.8M | — | ||
| Q2 24 | — | $-93.8M | ||
| Q1 24 | $-16.9M | $-102.0M | ||
| Q4 23 | — | $-104.0M | ||
| Q3 23 | — | $-104.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | — | ||
| Q2 24 | — | -546.6% | ||
| Q1 24 | — | -1038.1% | ||
| Q4 23 | — | -766.4% | ||
| Q3 23 | — | -1384.3% |
| Q4 25 | -2097.3% | — | ||
| Q3 25 | -3069.0% | — | ||
| Q2 25 | — | — | ||
| Q4 24 | -8344.1% | — | ||
| Q2 24 | — | -2412.1% | ||
| Q1 24 | -4247.4% | -5599.9% | ||
| Q4 23 | — | -4067.8% | ||
| Q3 23 | — | -6613.0% |
| Q4 25 | -1779.0% | — | ||
| Q3 25 | -2629.5% | — | ||
| Q2 25 | — | — | ||
| Q4 24 | -6973.7% | — | ||
| Q2 24 | — | -2222.2% | ||
| Q1 24 | -3200.8% | -5139.1% | ||
| Q4 23 | — | -3701.8% | ||
| Q3 23 | — | -6053.5% |
| Q4 25 | $-0.52 | — | ||
| Q3 25 | $-0.57 | — | ||
| Q2 25 | $-0.54 | — | ||
| Q4 24 | $-0.47 | — | ||
| Q2 24 | — | $-4.36 | ||
| Q1 24 | $-0.36 | $-5.10 | ||
| Q4 23 | — | $-14.49 | ||
| Q3 23 | — | $-5.57 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $742.2M | $775.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $752.6M | $394.8M |
| Total Assets | $791.6M | $1.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $742.2M | — | ||
| Q3 25 | $680.3M | — | ||
| Q2 25 | $661.1M | — | ||
| Q4 24 | $742.0M | — | ||
| Q2 24 | — | $775.7M | ||
| Q1 24 | $566.5M | $765.2M | ||
| Q4 23 | — | $874.0M | ||
| Q3 23 | — | $997.1M |
| Q4 25 | $752.6M | — | ||
| Q3 25 | $687.6M | — | ||
| Q2 25 | $670.4M | — | ||
| Q4 24 | $733.4M | — | ||
| Q2 24 | — | $394.8M | ||
| Q1 24 | $568.9M | $417.6M | ||
| Q4 23 | — | $505.5M | ||
| Q3 23 | — | $599.4M |
| Q4 25 | $791.6M | — | ||
| Q3 25 | $729.9M | — | ||
| Q2 25 | $701.4M | — | ||
| Q4 24 | $754.8M | — | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | $579.1M | $1.1B | ||
| Q4 23 | — | $1.2B | ||
| Q3 23 | — | $1.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-36.2M | $-79.1M |
| Free Cash FlowOCF − Capex | $-36.2M | $-113.5M |
| FCF MarginFCF / Revenue | -1560.0% | -2690.7% |
| Capex IntensityCapex / Revenue | 0.3% | 815.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-124.1M | $-458.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-36.2M | — | ||
| Q3 25 | $-38.9M | — | ||
| Q2 25 | $-28.0M | — | ||
| Q4 24 | $-20.7M | — | ||
| Q2 24 | — | $-79.1M | ||
| Q1 24 | $-26.0M | $-113.2M | ||
| Q4 23 | — | $-95.3M | ||
| Q3 23 | — | $-91.5M |
| Q4 25 | $-36.2M | — | ||
| Q3 25 | $-39.0M | — | ||
| Q2 25 | $-28.0M | — | ||
| Q4 24 | $-20.9M | — | ||
| Q2 24 | — | $-113.5M | ||
| Q1 24 | $-26.0M | $-126.3M | ||
| Q4 23 | — | $-113.7M | ||
| Q3 23 | — | $-104.8M |
| Q4 25 | -1560.0% | — | ||
| Q3 25 | -2340.4% | — | ||
| Q2 25 | — | — | ||
| Q4 24 | -4577.0% | — | ||
| Q2 24 | — | -2690.7% | ||
| Q1 24 | -4919.5% | -6362.8% | ||
| Q4 23 | — | -4046.9% | ||
| Q3 23 | — | -6066.1% |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 5.8% | — | ||
| Q2 25 | — | — | ||
| Q4 24 | 45.8% | — | ||
| Q2 24 | — | 815.5% | ||
| Q1 24 | 2.3% | 658.5% | ||
| Q4 23 | — | 653.9% | ||
| Q3 23 | — | 771.1% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
